![]() |
|
|
Vol. 27, Issue 1, 74-80, January 1999
Bio-organic Section, It was shown earlier that the monoterpene ketone, piperitenone (I)
is one of the major metabolites of R-(+)-pulegone, a potent hepatotoxin. In the present studies, the metabolic disposition of
piperitenone (I) was examined in rats. Piperitenone (I) was administered orally (400 mg/kg of the b. wt./day) to rats for 5 days.
The following urinary metabolites were isolated and identified by
various spectral analyses: p-cresol (VI),
6,7-dehydromenthofuran (III), p-mentha-1,3,5,8-tetraen-3-ol
(IX), p-mentha-1, 3,5-triene-3, 8-diol (X),
5-hydroxypiperitenone (VIII), 7-hydroxypiperitenone (XI),
10-hydroxypiperitenone (XII), and 4-hydroxypiperitenone (VII).
Incubation of piperitenone (I) with phenobarbital-induced rat liver
microsomes in the presence of NADPH resulted in the formation of five
metabolites which have been tentatively identified as metabolites III,
VII, VIII, XI, XII, on the basis of gas chromatography retention
time and gas chromatography-mass spectrometry analysis. Based on these
results, a probable mechanism for the formation of p-cresol
from piperitenone (I) via the intermediacy of metabolite III has been proposed.
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
Final Report on the Safety Assessment of Sodium p-Chloro-m-Cresol, p-Chloro-m-Cresol, Chlorothymol, Mixed Cresols, m-Cresol, o-Cresol, p-Cresol, Isopropyl Cresols, Thymol, o-Cymen-5-ol, and Carvacrol International Journal of Toxicology, January 1, 2006; 25(1_suppl): 29 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, P. Ma, M. Iszard, R. B. Cole, W. Wang, and G. Wang In Vitro Metabolism of R(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a Cannabinoid Receptor Agonist Drug Metab. Dispos., October 1, 2002; 30(10): 1077 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. Chen, E. H. Lebetkin, and L. T. Burka Metabolism of (R)-(+)-Pulegone in F344 Rats Drug Metab. Dispos., December 1, 2001; 29(12): 1567 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. V. Thulasiram, V. B. Bhat, and M. K. Madyastha Effect of Ring Size in R-(+)-Pulegone-Mediated Hepatotoxicity: Studies on the Metabolism of R-(+)-4-Methyl-2-(1-Methylethylidene)-Cyclopentanone and DL-Camphorone in Rats Drug Metab. Dispos., June 1, 2001; 29(6): 821 - 829. [Abstract] [Full Text] |
||||
![]() |
H. V. Thulasiram, A. K. Gadad, and M. K. Madyastha Role of C-5 Chiral Center in R-(+)-Pulegone-Mediated Hepatotoxicity: Metabolic Disposition and Toxicity of 5,5-Dimethyl-2-(1-Methylethylidene)-Cyclohexanone in Rats Drug Metab. Dispos., July 1, 2000; 28(7): 833 - 844. [Abstract] [Full Text] |
||||